News
MedGadget's MedTech Monday: Custom-fit degradable cranial implant
June 21, 2010 8:35 am | by Mass Device | CommentsA custom-fit degradable implant for filling bone defects after craniofacial surgery; a study shows Bard's LifeStent as superior to stentless angioplasty; Micrus' DeltaPAQ and DeltaPlush microcoils cleared in Japan; and CorMatrix's cardiac tissue repair wins CE Mark. ...
EarlySense wins FDA clearance for patient monitoring system
June 21, 2010 8:35 am | by Mass Device | CommentsIsraeli-based medical device company EarlySense Ltd. receives U.S. Food & Drug Administration approval to sell its EverOn Touch patient monitoring system in the United States. By Mary Vanac Ramat Gan, Israel-based medical device company EarlySense Ltd., which recently...
Docs increasingly abandon Medicare
June 21, 2010 7:36 am | by Mass Device | CommentsMore and more physicians are cutting Medicare patients from their rosters after Congress fails to stay a 21 percent reimbursement rate cut. As Congress allowed a 21 percent reduction in reimbursement rates for doctors to come into effect, the number of physicians pulling out of...
Encouraging results from the largest clinical study ever conducted on treating depression with Omega-3
June 21, 2010 6:38 am | by EurekAlert | Comments(Centre hospitalier de l'Université de Montréal) The use of Omega-3 supplements is effective among patients with major depression who do not have anxiety disorders, according to a study directed by Dr. Francois Lesperance of the Centre de recherche du Centre hospitalier at the...
FDA to expedite ev3's Pipeline
June 21, 2010 6:37 am | by Mass Device | CommentsThe Food & Drug Administration grants ev3 Inc. an expedited review of the pre-market approval application the company filed in May for its Pipeline cerebral aneurysm treatment. One of Covidien plc's (NYSE:COV) pending acquisitions won some good news from the Food & Drug...
Covidien registers for debt sale to cover $2.3 billion ev3 buyout
June 21, 2010 6:36 am | by Mass Device | CommentsCovidien plc registers for an offering of an undisclosed amount of debt, aimed at raising cash to help pay for its $2.3 billion buyout of ev3 Inc. Covidien plc (NYSE:COV) registered for a debt offering with the Securities & Exchange Commission, aiming to drum up some cash...
Sinapis Pharma Commences Phase I Trial
June 21, 2010 6:36 am | by Bio-Medicine.Org | CommentsJACKSONVILLE, Fla. , June 21 /- Sinapis Pharma, Inc. announces that its first patients were dosed in a Phase I clinical trial study on June 14, 2010 . This study, in human volunteers, is designed to evaluate the safety, pharmacokinetics, and absolute bioavailability of an intravenous...
Al Amal Hospital in Qatar Commences Treatments Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
June 21, 2010 6:36 am | by Bio-Medicine.Org | CommentsDOHA, Qatar , June 21 /- One of the leading cancer centers in the Middle East has become among the first in the region to introduce fast and efficient RapidArc® radiotherapy treatments from Varian Medical Systems (NYSE: VAR). Al Amal Hospital in Doha, Qatar , has treated nine brain...
U.S. FDA Approves Improved Performance of Riverain Medical's OnGuard Chest X-ray Computer-Aided Detection Technology
June 21, 2010 6:34 am | by Bio-Medicine.Org | CommentsDAYTON, Ohio , June 21 /- Riverain Medical® announced today that the U.S. Food and Drug Administration (FDA) has granted approval for the newest version of the OnGuard™ Chest X-ray Computer-Aided Detection (CAD) technology. OnGuard identifies solitary pulmonary nodules that may...
New possibility to determine the severity of appendicitis
June 21, 2010 6:34 am | by EurekAlert | Comments(University of Gothenburg) The symptoms of appendicitis are often diffuse and it can be difficult to obtain an accurate diagnosis early in the course of the disease. It may be possible to predict the severity from a blood sample, and in this way determine the treatment on an...
BD and PEPFAR Collaboration Initiates Program to Improve Blood-Drawing Practices in Clinics and Hospitals in Sub-Saharan Africa
June 21, 2010 6:34 am | by Becton, Dickinson and Company | Comments(June 21, 2010)Â -- BD (Becton, Dickinson and Company), a leading global medical technology company, and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Department of Health and Human Services' Centers for Disease Control an
ERT Announces New Report by TUFTS Identifying Growth in Adoption of Centralized ECG Services
June 21, 2010 6:34 am | by RealWire | CommentsPHILADELPHIA, 21 June 2010 - ERT, a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, announced today the availability of a new report, conducted by the Tufts Center for the Study of Drug Development, mapping the growing...
CardioGenics Selects Clinical Test Sites for Its High Speed Portable Blood Analyzer
June 21, 2010 6:33 am | by Bio-Medicine.Org | CommentsMISSISSAUGA, Ontario , June 21 /- CardioGenics Holdings Inc. (OTC Bulletin Board: CGNH), developer of the ultra-sensitive QL Careâ„¢ Point-Of-Care (POC) analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced the selection of four sites for...
Magic Power Coffee: Undeclared Drug Ingredient
June 21, 2010 6:30 am | by U.S. Food & Drug Administration | CommentsProduct marketed as a dietary supplement for sexual enhancement contains the drug ingredient hydroxythiohomosildenafil, a chemical that may interact with prescription nitrates, and cause dangerously low blood pressure.
Cardiovascular Devices Market Outlook June Update by ReportsandReports
June 21, 2010 4:37 am | by Bio-Medicine.Org | CommentsDALLAS , June 21, 2010 /- ReportsandReports announces it Will Carry Cardiovascular Devices Market Outlook 2016 June reports in its store. Netherlands Cardiovascular Devices Market Outlook to 2016 ( http://www.reportsandreports.com/market-reports/netherlands-cardiovascul......
